Abstract:Background This study aimed to evaluate the updated burden and temporal trends of cancer incidence and mortality in Asian countries. Methodology The data used in this study were retrieved from the Global Cancer Observatory, Cancer Incidence in Five Continents volumes I-XI, and the World Health Organization mortality database. These data were used to calculate the Average Annual Percentage Change (AAPC), with a 95% confidence interval (CI) by joinpoint regression analysis to determine the epidemiological trend in the past decade. Results In 2020, the cancer incidence in Asia was 169.1 per 1 00 000, accounting for 49.3% of the global cancer incidence. The most common cancers included lung (13.8%), breast (10.8%) and colorectal (10.6%) cancers. Its mortality was 101.6 per 1 00 000 (58.3% of the global cancer death) with lung (19.2%), liver (10.5%) and stomach (9.9%) cancers being the most common causes of cancer death. The cancer incidence had been increasing in female population, with Korea (AAPC = 5.73, 95% CI [5.30, 6.17], P < .001), Japan (AAPC = 2.67, 95% CI [2.12, 3.23], P < .001) and Kuwait (AAPC = 2.08, 95% CI [.49, 3.69], P = .016) showing the most significant increases in the past decade. The incidence increase was also observed among population aged <40 years old, with Korea (female AAPC = 8.42, 95% CI [7.40, 9.45], P < .001; male AAPC = 5.28, 95% CI [4.23, 6.33], P <.001), China (female AAPC = 2.94, 95% CI [2.07, 3.81], P < .001; male AAPC = 1.37, 95% CI [.57, 2.18], P = .004) and Japan (female AAPC = 2.88, 95% CI [1.88, 3.88], P = .016; male AAPC = 1.59, 95% CI [.40, 2.78], P = .015) showing the most significant increases. However, there was an overall decreasing trend of cancer mortality. Conclusions There was a substantial burden of cancer incidence and mortality in Asia. Although there was a decreasing trend in cancer mortality, its incidence had been increasing especially among female and younger populations. Future studies could be done to further investigate the potential reasons for these epidemiologic trends.

Prediction of Cancer Incidence and Mortality in Korea, 2018

Prediction of Cancer Incidence and Mortality in Korea, 2021

Prediction of Cancer Incidence and Mortality in Korea, 2022

Prediction of Cancer Incidence and Mortality in Korea, 2024

Prediction of Cancer Incidence and Mortality in Korea, 2023

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2021

Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2020

Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea

Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015

Breast Cancer Statistics in Korea, 2019

Individual 5-Year Lung Cancer Risk Prediction Model in Korea Using a Nationwide Representative Database

Time trends of colorectal cancer incidence and associated lifestyle factors in South Korea

Cancer Incidence and Mortality in Asian Countries: A Trend Analysis

Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004–2018

Gastric and colorectal cancer incidence attributable to dietary factors in Korea

Increasing Trend of Colorectal Cancer Incidence in Korea, 1999-2009